Add Yahoo as a preferred source to see more of our stories on Google. Q: My cousin was diagnosed with dystonia, what is this? A: Dystonia is a disorder of involuntary muscle contractions that may ...

Athetosis and chorea are two types of involuntary movements that can occur in children and adults with neurological conditions, such as cerebral palsy. The movements have different features, and the ...

Dyskinesia is when you experience involuntary movements. Chorea is one type of dyskinesia. It is associated with health conditions like Huntington’s disease, infection, or side effects of medications.

Nycole S. 42 of Winfield, Kansas, started her mental health journey when she was diagnosed with bipolar disorder in her teens. “When I was in high school, I was placed in a mental institution, which ...

Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...

Tardive dyskinesia is a bothersome side effect of certain medications that can cause grimacing, jaw clenching, lip puckering, and other involuntary movements. This disorder may affect as many as ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new insights ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD, PhD, of the ...

Chorea and hemiballismus are both forms of involuntary movement disorders. Hemiballismus can cause sudden, violent, and flinging motions. Chorea can cause irregular, spontaneous, and nonrepetitive ...

Forbes contributors publish independent expert analyses and insights. I am a physician and public health researcher This voice experience is generated by AI. Learn more. This voice experience is ...

Dec 22 (Reuters) - Neurocrine Biosciences (NBIX.O), opens new tab said on Monday its drug failed to meet the main goal in a late-stage clinical trial in patients with a type of disorder that disrupts ...